SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-23-043424
Filing Date
2023-12-01
Accepted
2023-12-01 16:38:34
Documents
5

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 146539
2 exd.htm EX-1 127545
3 exe.htm EX-2 89731
4 exf.htm EX-3 86572
5 exg.htm EX-4 81669
  Complete submission text file 0001493152-23-043424.txt   533754
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Subject) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-77935 | Film No.: 231460094
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1099 FOREST LAKE TERRACE NICEVILLE FL 32578
Business Address 1099 FOREST LAKE TERRACE NICEVILLE FL 32578 208-263-6695
10X Fund, L.P. (Filed by) CIK: 0001453356 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A